Article
Rheumatoid arthritis (RA) has long been established to have pulmonary manifestations such as interstitial lung disease (ILD), and several research groups are pursuing this respiratory burden of RA at #ACR20.
All News
Article
Here are my highlights from day four, Monday, of the ACR 2020 Convergence.
Vaccine Immunogenicity with Tofacitinib
Dr. John Cush
Tweet
Watch this three minute video on Subclinical Synovitis with Dr Eric Dein ( @ejdein1) #ACR20
https://t.co/rGqgseyWBv https://t.co/6snzAjbuaU
Dr. John Cush
Tweet
Significance of ANA+ in Managing RA with Dr Eric Dein ( @ejdein1) #ACR20
https://t.co/LdRaPNyJgq https://t.co/yuPq49hoLq
Dr. John Cush
Tweet
Have five minutes to spare? Check out this video titled, "HCQ and QTc in RA and SLE Patient" with Dr. Kathryn Dao ( @KDAO2011). #ACR20
https://t.co/EY6LPX25Bn https://t.co/wRM61hMelo
Dr. John Cush
Tweet
#BestACR20Tweets
RT @RichardPAConway Dr Lillegraven presents a randomized open-label phase 4, non-Inferiority trial of TNFi tapering in RA patients in sustained remission. 63% of tapered patients flared over 12 months vs 5% of maintained. https://t.co/JwR86kJf56 https://t.co/fFRVf6TYf9
Dr. John Cush
Tweet
Check out this quick video on lifestyle, clinical risk factors for RA-ILD with Dr. Sheila Reyes (@RHEUMarampa) #ACR20
https://t.co/7LQ7RCtiuj https://t.co/CjjtUauy2u
Dr. John Cush
Tweet
XRay Bone Erosions in CCP+ Patients with Dr Eric Dein ( @ejdein1) #ACR20
https://t.co/f6RnoExBgk https://t.co/MJCp3sR1UZ
Dr. John Cush
Tweet
Check out this video on combo therapy v monotherapy (SEAM-RA Trial) with Dr. Richard Conway (@RichardPAConway). #ACR20
https://t.co/iNsmKHSnMq https://t.co/tELmueVEK0
Dr. John Cush
Tweet
What is the SEAMless transition from combination Etanercept to Methotrexate? Dr. Jonathan Kay takes a deep dive into plenary abstract #0939 presented at #ACR20 annual meeting, reviewing two previous clinical trials that also looked at this question.
https://t.co/58raeaE8Mr https://t.co/ZP2P0IZ1Fc
Dr. John Cush
Tweet
View one of our fantastic #ACR20 video titled "Staying on Therapy in RA" with Dr. Janet Pope ( @Janetbirdope)
https://t.co/imCpxVs2N8 https://t.co/AcTBGaapig
Dr. John Cush
Tweet
What is the SEAMless transition from combination Etanercept to Methotrexate? with Dr. Jonathan Kay #ACR20
https://t.co/58raeaE8Mr https://t.co/FUIidcoy4I
Dr. John Cush
Tweet
Improving Drug Adherence in RA: Dr Janet Pope ( @Janetbirdope) Reviews abstract #799 presented at #ACR20.
https://t.co/ONCJmCOdzC https://t.co/ornpQiopTS
Dr. John Cush
Tweet
SEAM-RA Trial: Dr. Jeff Curtis ( @RADoctor) discusses abstract # 0939 that looked at whether RA patients at or close to remission should continue taking their combination therapy, as presented at #ACR20
https://t.co/2yMyj4BKs1 https://t.co/2gqJM4EKpG
Dr. John Cush
Tweet
Revisiting Day 1 of #ACR20. Watch our video on what to do with subclinical synovitis. https://t.co/ynSRjiAFPe https://t.co/XeeGohW8t5
Dr. John Cush
Tweet
How are RA patients doing using telemedicine/virtual care? Dr. Janet Pope ( @Janetbirdope) weighs in. #ACR20
https://t.co/YffT28OwgY https://t.co/OvpBDwkyEp
Dr. John Cush
Tweet
An International Panel Weighs in on RA Studies from Day 1 at #ACR20
https://t.co/T8mhuRYVbf https://t.co/pMPV4bxYGK
Dr. John Cush
Tweet
"Rheumatoid arthritis and lung disease in the spotlight at #ACR20" by Dr. Jeffrey Sparks ( @jeffsparks)
https://t.co/0Dth0ko5TO https://t.co/e6HQOkXuY7
Dr. John Cush
Tweet
Racial Disparities - Stroke, Heart Attacks Risks Higher in SLE: Dr. Kathryn Dao ( @KDAO2011) discusses abstract #0433 presented Friday at #ACR20 annual meeting.
https://t.co/Jx8hiPcNKA https://t.co/MvUj41KiuQ
Dr. John Cush
Tweet
Read our news article "Ten-Year Analysis of Low-Dose Glucocorticoids in early RA" by Meral K. El Ramahi ( @MeralElRamahiMD) #ACR20.
https://t.co/S9rOHc0864 https://t.co/6X4owP6pF0
